These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25079464)

  • 1. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
    Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
    Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.
    Al-azzam SI; Alkhateeb AM; Al-Azzeh O; Alzoubi KH; Khabour OF
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):300-5. PubMed ID: 23329579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Arici M; Oztas E; Yanar F; Aksakal N; Ozcinar B; Ozhan G
    Endocr J; 2018 Mar; 65(3):317-323. PubMed ID: 29321381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild TSH resistance: Clinical and hormonal features in childhood and adulthood.
    Vigone MC; Di Frenna M; Guizzardi F; Gelmini G; de Filippis T; Mora S; Caiulo S; Sonnino M; Bonomi M; Persani L; Weber G
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):587-596. PubMed ID: 28561265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
    Fallahi P; Ferrari SM; Antonelli A
    Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Thyroid-Stimulating Hormone Levels and Body Mass Index Percentiles in Children with Primary Hypothyroidism on Levothyroxine Replacement.
    Shaoba A; Basu S; Mantis S; Minutti C
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):337-343. PubMed ID: 28766504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF.
    Busnelli A; Vannucchi G; Paffoni A; Faulisi S; Fugazzola L; Fedele L; Somigliana E
    Eur J Endocrinol; 2015 Oct; 173(4):417-24. PubMed ID: 26139211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
    Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
    J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
    Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
    Livingston M; Birch K; Guy M; Kane J; Heald AH
    Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects.
    Samuels MH; Kolobova I; Niederhausen M; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2018 May; 103(5):1997-2008. PubMed ID: 29509918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
    Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
    Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED): protocol for a mixed methods feasibility study to assess the clinical utility of lower dose thyroxine in elderly hypothyroid patients: study protocol for a randomized controlled trial.
    Wilkes S; Pearce S; Ryan V; Rapley T; Ingoe L; Razvi S
    Trials; 2013 Mar; 14():83. PubMed ID: 23522096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid Function Variation in the Normal Range, Energy Expenditure, and Body Composition in L-T4-Treated Subjects.
    Samuels MH; Kolobova I; Antosik M; Niederhausen M; Purnell JQ; Schuff KG
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2533-2542. PubMed ID: 28460140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
    Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
    Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
    Fallahi P; Ferrari SM; Antonelli A
    Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.